WEKO3
アイテム
{"_buckets": {"deposit": "e9b848d7-661c-4c9e-b799-34f3a2179435"}, "_deposit": {"created_by": 1, "id": "58563", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "58563"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00058563", "sets": ["11"]}, "author_link": ["585432", "585434", "585433"], "item_10004_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2015-04", "bibliographicIssueDateType": "Issued"}, "bibliographic_titles": [{"bibliographic_title": "Journal of Nuclear Cardiology"}]}]}, "item_10004_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Nuclear cardiology imaging tests are widely performed in Japan as clinical practice. The Japanese nuclear cardiology community has developed new diagnostic imaging tests using 123I-beta-methyl-p-iodophenyl-pentadecanoic acid (BMIPP), 123I-metaiodobenzylguanidine (MIBG), and 18F-fluorodeoxyglucose (FDG) PET for detecting cardiac involvement in sarcoidosis. These tests have become popular worldwide. The Japanese Circulation Society (JCS) and the Japanese Society of Nuclear Cardiology (JSNC) have published clinical imaging guidelines showing indications and standards for the new imaging tests. JSNC is currently striving to improve the standard of clinical practice and is promoting research activities.", "subitem_description_type": "Abstract"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Yoshinaga, Keiichiro"}], "nameIdentifiers": [{"nameIdentifier": "585432", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tamaki, Nagara"}], "nameIdentifiers": [{"nameIdentifier": "585433", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "吉永 恵一郎", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "585434", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence"}]}, "item_type_id": "10004", "owner": "1", "path": ["11"], "permalink_uri": "https://repo.qst.go.jp/records/58563", "pubdate": {"attribute_name": "公開日", "attribute_value": "2015-08-14"}, "publish_date": "2015-08-14", "publish_status": "0", "recid": "58563", "relation": {}, "relation_version_is_last": true, "title": ["Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence"], "weko_shared_id": -1}
Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence
https://repo.qst.go.jp/records/58563
https://repo.qst.go.jp/records/58563f45b6b21-474f-4646-b74e-62be3dee6dfb
Item type | 一般雑誌記事 / Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2015-08-14 | |||||
タイトル | ||||||
タイトル | Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Yoshinaga, Keiichiro
× Yoshinaga, Keiichiro× Tamaki, Nagara× 吉永 恵一郎 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Nuclear cardiology imaging tests are widely performed in Japan as clinical practice. The Japanese nuclear cardiology community has developed new diagnostic imaging tests using 123I-beta-methyl-p-iodophenyl-pentadecanoic acid (BMIPP), 123I-metaiodobenzylguanidine (MIBG), and 18F-fluorodeoxyglucose (FDG) PET for detecting cardiac involvement in sarcoidosis. These tests have become popular worldwide. The Japanese Circulation Society (JCS) and the Japanese Society of Nuclear Cardiology (JSNC) have published clinical imaging guidelines showing indications and standards for the new imaging tests. JSNC is currently striving to improve the standard of clinical practice and is promoting research activities. | |||||
書誌情報 |
Journal of Nuclear Cardiology 発行日 2015-04 |